Welcome to the SPHERE Insights Blog. In this space, we'll share perspectives from our team of clinical research experts on the challenges, opportunities, and innovations shaping clinical trials today. We begin with a topic we're passionate about: collaboration in clinical research.
Clinical research has always depended on strong partnerships. Today, that need is greater than ever. Trials are becoming more complex, data sources are expanding, and sponsors, investigators, clinicians, and health systems are being asked to work together with greater speed, precision, and accountability.
Meaningful collaboration across academic research sites and industry sponsors is essential to clinical research that is rigorous, relevant, and meaningful.
Why Collaboration Matters
Successful clinical research brings together scientific leadership, operational delivery, regulatory knowledge, technical expertise, and patient engagement – all across different teams from the site, CRO and sponsor. When these groups collaborate from the start, teams can anticipate challenges earlier, achieve timelines, and keep the study focused on key outcomes.
How SPHERE Supports Collaborative Research
As an academic–industry CRO based within St. Michael’s Hospital, part of Unity Health Toronto, and affiliated with the University of Toronto, SPHERE operates at the intersection of healthcare, academia, and industry. We partner with hospital institutions, academic research centres, pharmaceutical companies, biotechs, and medical device start-ups to advance innovative research projects. By combining the standards of an academic research organization with the accountability of a full-service CRO, SPHERE bridges the gap between academia and industry to help sponsors and investigators align priorities, reduce friction, and generate evidence that is credible, practical, and relevant to healthcare decision-making.
What Effective Collaboration Looks Like
A recent case study at SPHERE and Unity Health shows how collaboration can directly improve access to clinical trials. SPHERE supports the site and performance management activities of Unity’s Preferred Partnership Model with Roche and other industry partners, so studies can move from planning to activation much faster. This approach has helped shorten typical clinical trial start-up timelines from an average of 6-12 months to 45 calendar days, giving research teams more time to recruit participants, generate evidence, and connect patients with innovative treatment options sooner.
For sponsors, this means faster study activation, greater predictability, and earlier access to critical data. For research sites, it creates stronger collaboration, reduced administrative burden, and more efficient operations. And for patients, it means quicker access to innovative clinical trials and potential new treatment options.
Research That Goes Further, Together
When industry sponsors, academic research sites, CROs and healthcare organizations align around shared goals, everyone benefits. The result is a more agile research ecosystem that helps advance medical innovation while improving access to clinical research opportunities.
Key Takeaways
- Modern clinical research depends on effective collaboration across research teams from industry sponsors, CROs and academic research sites.
- As a hospital-based, academically-affiliated CRO, SPHERE can uniquely bridge industry and academia to advance innovative clinical research together.
- SPHERE’s site and performance management services allowed a large hospital network’s partnership model the adoption of a framework for effective research collaboration, reducing average start-up timelines from 6-12 months to 45 days.
- Integrated research collaboration helps move innovative ideas into high-quality evidence that can improve patient care.
Stay connected with SPHERE Insights for future articles from our team, event updates, and our latest publications advancing clinical research.
